Understanding clinical heterogeneity in attention deficit hyperactivity disorder (ADHD) is important for improving personalized care and long-term outcomes. A study exploits the large scale and breadth of phenotyping of the iPSYCH cohort to link clinical heterogeneity to genetic heterogeneity in ADHD.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Demontis, D. et al. Nat. Genet. 55, 198–208 (2023).
Demontis, D. et al. Nat. Genet. 51, 63–75 (2019).
Grotzinger, A. D. et al. Nat. Genet. 54, 548–559 (2022).
LaBianca, S. et al. Nat. Genet. https://doi.org/10.1038/s41588-023-01593-7 (2023).
Mattheisen, M. et al. Nat. Genet. 54, 1470–1478 (2022).
Satterstrom, F. K. et al. Nat. Neurosci. 22, 1961–1965 (2019).
Acknowledgements
J.G. is supported by the Australian National Health and Medical Research Council (GNT2018431) and Mater Foundation.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Yap, C.X., Gratten, J. Connecting clinical and genetic heterogeneity in ADHD. Nat Genet 56, 195–196 (2024). https://doi.org/10.1038/s41588-024-01652-7
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41588-024-01652-7
